Mechanisms of G2 arrest in response to overexpression of p53

Molecular Biology of the Cell

Volumn 10, Issue 11, 1999, Pages 3607-3622

  Taylor, William R ^a   DePrimo, Samuel E ^a   Agarwal, Archana ^a   Agarwal, Munna L ^a   Schönthal, Axel H ^b   Katula, Karen S ^c   Stark, George R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Division of Hematology   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELL CYCLE G2 PHASE; CELL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0032743748     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.11.3607     Document Type: Article

References (82)

1. Agarwal, M.L., Agarwal, A., Taylor, W.R., Chernova, O., Sharma, Y., and Stark, G.R. (1998a). A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc. Natl. Acad. Sci. USA 95, 14775-14780.
2. Agarwal, M.L., Agarwal, A., Taylor, W.R., and Stark, G.R. (1995). p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493-8497.
3. Agarwal, M.L., Taylor, W.R., Chernov, M.V., Chernova, O.B., and Stark, G.R. (1998b). The p53 network. J. Biol. Chem. 273, 1-4.
4. Azzam, E.I., de Toledo, S.M., Pykett, M.J., Nagasawa, H., and Little, J.B. (1997). CDC2 is down-regulated by ionizing radiation in a p53-dependent manner. Cell Growth Differ. 8, 1161-1169.
5. Booher, R.N., Holman, P.S., and Fattaey, A. (1997). Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem. 272, 22300-22306.
6. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W., and Vogelstein, B. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501.
7. Ceraline, J., Deplanque, G., Duclos, B., Limacher, J.M., Hajri, A., Noel, F., Orvain, C., Frebourg, T., Klein-Soyer, C., and Bergerat, J.P. (1998). Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents. Int. J. Cancer 75, 432-438.
8. Chen, J.J., Reid, C.E., Band, V., and Androphy, E.J. (1995). Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269, 529-531.
9. Chen, X., Ko, L.J., Jayaraman, L., and Prives, C. (1996). p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10, 2438-2451.
10. Chernova, O.B., Chernov, M.V., Agarwal, ML., Taylor, W.R., and Stark, G.R. (1995). The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem. Sci. 20, 431-434.
11. Cross, S.M., Sanchez, C.A., Morgan, C.A., Schimke, M.K., Ramel, S., Idzerda, R.L., Raskind, W.H., and Reid, B.J. (1995). A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356.
12. de Toledo, S.M., Azzam, E.I., King, P., Laffrenier, S., and Little, J.B. (1998). Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1. Cell Growth Differ. 9, 887-896.
13. Di Leonardo, A., Linke, S.P., Clarkin, K., and Wahl, G.M. (1994). DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540-2551.
14. Draetta, G., and Beach, D. (1988). Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54, 17-26.
15. Draetta, G., and Eckstein, J. (1997). Cdc25 protein phosphatases in cell proliferation. Biochim. Biophys. Acta 1332, M53-M63.
16. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J., and Reed, S.I. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023.
17. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
18. Fisher, R.P., and Morgan, D.O. (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78, 713-724.
19. Fritsche, M., Haessler, C., and Brandner, G. (1993). Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-318 [erratum (1993) 8, 2605].
20. Furnari, B., Rhind, N., and Russell, P. (1997). Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277, 1495-1497.
21. Gao, Q., Srinivasan, S., Boyer, S.N., Wazer, D.E., and Band, V. (1999). The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19, 733-744.
22. Giaccia, A.J., and Kastan, M.B. (1998). The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983.
23. Guadagno, T.M., and Newport, J.W. (1996). Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 84, 73-82.
24. Gujuluva, C.N., Baek, J.H., Shin, K.H., Cherrick, H.M., and Park, N.H. (1994). Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene 9, 1819-1827.
25. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
26. Harper, J.W., et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
27. Hermeking, H., Lengauer, C., Polyak, K., He, T.C., Zhang, L., Thiagalingam, S., Kinzler, K.W., and Vogelstein, B. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11.
28. Hitomi, M., Shu, J., Agarwal, M., Agarwal, A., and Stacey, D.W. (1998). p21Waf1 inhibits the activity of cyclin dependent kinase 2 by preventing its activating phosphorylation. Oncogene 17, 959-969.
29. Hughes, T.A., and Cook, P.R. (1996). Mimosine arrests the cell cycle after cells enter S-phase. Exp. Cell Res. 222, 275-280.
30. Hupp, T.R., Sparks, A., and Lane, D.P. (1995). Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-245.
31. Hwang, A., Maity, A., McKenna, W.G., and Muschel, R.J. (1995). Cell cycle-dependent regulation of the cyclin B1 promoter. J. Biol. Chem. 270, 28419-28424.
32. Hwang, A., and Muschel, R.J. (1998). Radiation and the G2 phase of the cell cycle. Radiat. Res. 150, S52-S59.
33. Imai, T., et al. (1997). ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors. Biochem. Biophys. Res. Commun. 233, 765-769.
34. Innocente, S.A., Abrahamson, J.L., Cogswell, J.P., and Lee, J.M. (1999). p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA 96, 2147-2152.
35. Jin, P., Hardy, S., and Morgan, D.O. (1998). Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141, 875-885.
36. Kao, G.D., McKenna, W.G., Maity, A., Blank, K., and Muschel, R.J. (1997). Cyclin B1 availability is a rate-limiting component of the radiation-induced G2 delay in HeLa cells. Cancer Res. 57, 753-758.
37. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
38. Katula, K.S., Wright, K.L., Paul, H., Surman, D.R., Nuckolls, F.J., Smith, J.W., Ting, J.P., Yates, J., and Cogswell, J.P. (1997). Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements. Cell Growth Differ. 8, 811-820.
39. Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., and Ishibashi, M. (1997). Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94, 11612-11616.
40. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
41. Larochelle, S., Pandur, J., Fisher, R.P., Salz, H.K., and Suter, B. (1998). Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activity. Genes Dev. 12, 370-381.
42. Leach, S.D., Scatena, C.D., Keefer, C.J., Goodman, H.A., Song, S.Y., Yang, L., and Pietenpol, J.A. (1998). Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res. 58, 3231-3236.
43. Leffers, H., Madsen, P., Rasmussen, H.H., Honore, B., Andersen, A.H., Walbum, E., Vandekerckhove, J., and Celis, J.E. (1993). Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signaling pathway. J. Mol. Biol. 231, 982-998.
44. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
45. Linke, S.P., Clarkin, K.C., DiLeonardo, A., Tsou, A., and Wahl, G.M. (1996). A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10, 934-947.
46. Liu, F., Stanton, J.J., Wu, Z., and Piwnica-Worms, H. (1997). The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol. 17, 571-583.
47. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-852.
48. Maltzman, W., and Czyzyk, L. (1984). UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4, 1689-1694.
49. Matsuoka, S., Huang, M., and Elledge, S.J. (1998). Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893-1897.
50. McGowan, C.H., and Russell, P. (1993). Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J. 12, 75-85.
51. Murray, A.W., Solomon, M.J., and Kirschner, M.W. (1989). The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature 339, 280-286.
52. Niculescu, A. B., III, Chen, X., Smeets, M., Hengst, L., Prives, C., and Reed, S.I. (1998). Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629-643.
53. Notterman, D., Young, S., Wainger, B., and Levine, A.J. (1998). Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity. Oncogene 17, 2743-2751.
54. Nuckolls, F.J., Khan, A.S., Butler, R., and Katula, K.S. (1998). Differential response of the human cyclin B1 promoter to inhibitors of the cell cycle in NIH3T3 cells. Biochem. Biophys. Res. Commun. 244, 280-284.
55. Nurse, P. (1990). Universal control mechanism regulating onset of M-phase. Nature 344, 503-508.
56. Parker, L.L., and Piwnica-Worms, H. (1992). Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257, 1955-1957.
57. Peng, C.Y., Graves, P.R., Ogg, S., Thoma, R.S., Byrnes, M. J., III, Wu, Z., Stephenson, M.T., and Piwnica-Worms, H. (1998). C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ. 9, 197-208.
58. Peng, C.Y., Graves, P.R., Thoma, R.S., Wu, Z., Shaw, A.S., and Piwnica-Worms, H. (1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505.
59. Pietenpol, J.A., Tokino, T., Thiagalingam, S., El-Deiry, W.S., Kinzler, K.W., and Vogelstein, B. (1994). Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91, 1998-2002.
60. Pines, J. (1995). Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308, 697-711.
61. Poon, R.Y., Chau, M.S., Yamashita, K., and Hunter, T. (1997). The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57, 5168-5178.
62. Rosenblatt, J., Gu, Y., and Morgan, D.O. (1992). Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA 89, 2824-2828.
63. Sambrook, J., Frisch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor University Press.
64. Sanchez, Y., Wong, C., Thoma, R.S., Richman, R., Wu, Z., Piwnica-Worms, H., and Elledge, S.J. (1997). Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497-1501.
65. Schneider, E., Montenarh, M., and Wagner, P. (1998). Regulation of CAK kinase activity by p53. Oncogene 17, 2733-2741.
66. Smith, K.A., Gorman, P.A., Stark, M.B., Groves, R.P., and Stark, G.R. (1990). Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63, 1219-1227.
67. Stewart, N., Hicks, G.G., Paraskevas, F., and Mowat, M. (1995). Evidence for a second cell cycle block at G2/M by p53. Oncogene 10, 109-115.
68. Sugarman, J.L., Schonthal, A.H., and Glass, C.K. (1995). Identification of a cell-type-specific and E2F-independent mechanism for repression of cdc2 transcription. Mol. Cell. Biol. 15, 3282-3290.
69. Taylor, W.R., Agarwal, M.L., Agarwal, A., Stacey, D.W., and Stark, G.R. (1999). p53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene 18, 283-295.
70. Thompson, D.A., Belinsky, G., Chang, T.H., Jones, D.L., Schlegel, R., and Munger, K. (1997). The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene 15, 3025-3035.
71. Tsai, L.H., Harlow, E., and Meyerson, M. (1991). Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature 353, 174-177.
72. Utrera, R., Collavin, L., Lazarevic, D., Delia, D., and Schneider, C. (1998). A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression. EMBO J. 17, 5015-5025.
73. Vogt, M., Haggblom, C., Yeargin, J., Christiansen-Weber, T., and Haas, M. (1998). Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ. 9, 139-146.
74. Wang, Q., Zambetti, G.P., and Suttle, D.P. (1997). Inhibition of DNA topoisomerase II alpha gene expression by the p53 rumor suppressor. Mol. Cell. Biol. 17, 389-397.
75. Wang, X.Q., Gabrielli, B.G., Milligan, A., Dickinson, J.L., Antalis, T.M., and Ellem, K.A. (1996). Accumulation of p16CDKN2A in response to UV irradiation correlates with late S-G(2)-phase cell cycle delay. Cancer Res. 56, 2510-2514.
76. Watanabe, N., Broome, M., and Hunter, T. (1995). Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J. 14, 1878-1891.
77. Welch, P.J., and Wang, J.Y. (1992). Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 89, 3093-3097.
78. White, R.A., Terry, N.H., Meistrich, M.L., and Calkins, D.P. (1990). Improved method for computing potential doubling time from flow cytometric data. Cytometry 11, 314-317.
79. Winters, Z.E., Ongkeko, W.M., Harris, A.L., and Norbury, C.J. (1998). p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells. Oncogene 17, 673-684.
80. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
81. Yankulov, K.Y., and Bentley, D.L. (1997). Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16, 1638-1646.
82. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C., and Wahl, G.M. (1992). Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948.